Notices to creditors (MVL)
PHOSPHATE THERAPEUTICS LTD.
The joint liquidators of Phosphate Therapeutics Ltd intend to make a final distribution to creditors, with a proof deadline of 25 September 2026.
Notice details
- Company
- PHOSPHATE THERAPEUTICS LTD
- Company number
- 07618820
- Registered office
- 12 Wellington Place, Leeds, LS1 4AP
- Liquidator(s)
- Trevor Oates (IP number 26290) of Ernst & Young LLP, 12 Wellington Place, Leeds, LS1 4AP; Derek Neil Hyslop (IP number 9970) of Ernst & Young LLP, Atria One, 144 Morrison Street, Edinburgh, EH3 8EX
- Date of appointment
- 31 July 2026
- Last date for proving
- 25 September 2026
- Contact
- Mark Chapman on +44 113 298 2602
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If PHOSPHATE THERAPEUTICS LTD. owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2 has backed and restructured UK businesses since 1990, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at PHOSPHATE THERAPEUTICS LTD. or something similar, start the conversation early.
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2 has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.